Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-04

Clinical Trial Update: A Study of HSK21542 in a Peritoneal Dialysis Pruritus Population. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for HSK21542 in patients with pruritus associated with peritoneal dialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HSK21542

Snippet

Sponsor: Xizang Haisco Pharmaceutical Co., Ltd | Conditions: Pruritus | Phase 2 | Status: UNKNOWN